Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. is a foreign invested pharmaceutical stocks company with a registered capital of RMB 99 million and a fixed assets of RMB 180 million, which was approved by Ministry of Foreign Trade and Economic Cooperation on Dec.19, 2001 after stocks transformation on the base of original Lianyungang Chia Tai-Tianqing Pharmaceutical Co., Ltd.

Jiangsu Chia Tai-Tianqing Pharmaceutical Company is a large comprehensive pharmaceutical manufacturer, which integrates medicine and natural extract's R&D, manufacturing and marketing as a whole. All the company's workshops producing injections, tablets, capsules and raw materials have gained GMP certificates issued by State Food & Drug Administration, P.R. China. What's more, raw materials workshop for Foscarnet Sodium has passed the U.S. FDA approval. We also own an entire distribution system, with 72 offices around China, and an excellent team of sale-representatives.

In order to promote rapid development, our company built up Nanjing Chia Tai-Tianqing Pharmaceutical Co., Ltd., Jiangsu Provincial Engineering & Technical Center for New Type Medicines Curing Liver Diseases, and Postal-doctor Work Station of Science and Research in recent years.

Enjoying high reputation in domestic medicine circle, we also make great efforts promoting our products to the overseas market. Now, our products such as Foscarnet Sodium, Grape Seed Extract and some other products have been exported to the USA, Japan, some European countries and so on. We sincerely hope to cooperate with customers from home and abroad by providing our high quality products, reasonable prices and best service.

"For human health, for splendid future" is the eternal aim of CTTQ. The staffs are striving to build up a pharmaceutical power of the first rate and contribute more to the human health in the world.